Abstract |
Hepatocyte growth factor (HGF) overexpression is an important mechanism in acquired epidermal growth factor receptor (EGFR) kinase inhibitor gefitinib resistance in lung cancers with EGFR activating mutations. MiR-1-3p and miR-206 act as suppressors in lung cancer proliferation and metastasis. However, whether miR-1-3p and miR-206 can overcome HGF-induced gefitinib resistance in EGFR mutant lung cancer is not clear. In this study, we showed that miR-1-3p and miR-206 restored the sensitivities of lung cancer cells PC-9 and HCC-827 to gefitinib in present of HGF. For the mechanisms, we demonstrated that both miR-1-3p and miR-206 directly target HGF receptor c-Met in lung cancer. Knockdown of c-Met mimicked the effects of miR-1-3p and miR-206 transfections Meanwhile, c-Met overexpression attenuated the effects of miR-1-3p and miR-206 in HGF-induced gefitinib resistance of lung cancers. Furthermore, we showed that miR-1-3p and miR-206 inhibited c-Met downstream Akt and Erk pathway and blocked HGF-induced epithelial-mesenchymal transition (EMT). Finally, we demonstrated that miR-1-3p and miR-206 can increase gefitinib sensitivity in xenograft mouse models in vivo. Our study for the first time indicated the new function of miR-1-3p and miR-206 in overcoming HGF-induced gefitinib resistance in EGFR mutant lung cancer cell.
|
Authors | Demin Jiao, Jun Chen, Yu Li, Xiali Tang, Jian Wang, Wei Xu, Jia Song, You Li, Huimin Tao, Qingyong Chen |
Journal | Journal of cellular and molecular medicine
(J Cell Mol Med)
Vol. 22
Issue 7
Pg. 3526-3536
(07 2018)
ISSN: 1582-4934 [Electronic] England |
PMID | 29664235
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. |
Chemical References |
- Antineoplastic Agents
- HGF protein, human
- MIRN1 microRNA, human
- MIRN206 microRNA, human
- MicroRNAs
- Hepatocyte Growth Factor
- EGFR protein, human
- ErbB Receptors
- MET protein, human
- Proto-Oncogene Proteins c-met
- Gefitinib
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, metabolism, pathology)
- Cell Line, Tumor
- Drug Resistance, Neoplasm
(drug effects, genetics)
- Epithelial-Mesenchymal Transition
(drug effects)
- ErbB Receptors
(genetics)
- Gefitinib
(pharmacology)
- Gene Expression Regulation, Neoplastic
- Hepatocyte Growth Factor
(genetics, metabolism, pharmacology)
- Humans
- Liver Neoplasms
(drug therapy, metabolism, pathology)
- Male
- Mice, Inbred BALB C
- MicroRNAs
(genetics)
- Proto-Oncogene Proteins c-met
(genetics, metabolism)
- Signal Transduction
- Xenograft Model Antitumor Assays
|